Papers/PMID:27851868
Pharmacotherapies for sleep disturbances in dementia.
The Cochrane database of systematic reviews2016The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
melatonin — no detected effect on activities of daily living score
PreliminaryGrade D, Preliminary. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“From two studies, we found no effect of melatonin on cognition or performance of activities of daily living (ADL).”
Quoted verbatim from Pharmacotherapies for sleep disturbances in dementia.. - Study
- meta-analysis
- Population
- patients with moderate-to-severe Alzheimer's disease dementia and an identified sleep disturbance, melatonin doses up to 10 mg; no specific ADL instrument named
Pharmacotherapies for sleep disturbances in dementia.2016PMID:27851868Permalink